FU was partly supported by grants from the NIH/NIDDK (DK132090, DK020579) and the NIH/National Center for Advancing Translational Sciences (NCATS) (TR002065, TR000448) and philanthropic support from the Silberman Fund, the Ellie White Foundation for Rare Genetic Disorders, the Snow Foundation, the Unravel Wolfram Syndrome Fund, the Stowe Fund, the Feiock Fund, the Cachia Fund, the Gildenhorn Fund, the Eye Hope Foundation, Ontario Wolfram League, Associazione GentianSindrome di Wolfram Italia, Alianza de Familias Afectadas por el Sindrome Wolfram Spain, Wolfram Syndrome UK and the Association Syndrome de Wolfram France
A recent study demonstrated that l-carnitine has a protective effect via anti-inflammatory and antioxidant mechanisms in the MIA-induced KOA rat model [22]
Semaglutide, tirzepatide, and the broader GLP-1 RA class are peptide-based drugs generating tens of billions in global sales
LEADER compared liraglutide to placebo in 9340 patients with T2DM and known CV disease or CV risk factors only [16]
